Showing results (1791-1800 of 14,964) with videos related to
Sort By:
Pageof 1,497
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress conditionBarbara Frossi, Juan Rivera, Emilio Hirsch, et al.Chemical Communications (Cambridge, England)|February 1, 2007
A chiral dumbbell shaped bis(fullerene) oligoelectrolyteNikos Chronakis, Uwe Hartnagel, Martin Braun, et al.The Medical Journal of Australia|December 2, 1991
Admissions for suspected snake bite to the Perth adult teaching hospitals, 1979 to 1988G A Jelinek, T Hamilton, R L HirschInternational Journal of Andrology|December 1, 1991
Evaluation of the acrosome reaction using monoclonal antibodies against different acrosomal antigens--comparison with the triple stain techniqueJ Braun, T Hirsch, W Krause, et al.AJNR. American Journal of Neuroradiology|October 13, 2006
Fluoroscopic and CT fistulography of the first branchial cleftJ Whetstone, B F Branstetter, B E HirschClinical Science (London, England : 1979)|December 21, 2020
Potential therapeutic applications of AKAP disrupting peptidesAlessandra Murabito, Sophie Cnudde, Emilio Hirsch, et al.Cancer Journal (Sudbury, Mass.)|December 10, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Status and Future DirectionsSheena Bhalla, Deborah Blythe Doroshow, Fred R HirschFrontiers in Oncology|May 10, 2013
Targeting PI3K in Cancer: Any Good News?Miriam Martini, Elisa Ciraolo, Federico Gulluni, et al.Military Medicine|May 28, 2013
Efficacy of stellate ganglion block in the treatment of anxiety symptoms from combat-related post-traumatic stress disorder: a case seriesJustin Alino, Donald Kosatka, Brian McLean, et al.Current Opinion in Oncology|February 7, 2013
The role of anaplastic lymphoma kinase inhibitors in the treatment of advanced nonsmall cell lung cancerManolo D'Arcangelo, Murry W Wynes, Fred R HirschPageof 1,497